Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (248)
  3. Review (13)
  4. Guidelines (11)
  5. Research Letter (9)
  6. Book Section (6)
  7. Correspondence (5)
  8. Editorial (4)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (671)
  2. Department of Medicine (671)
  3. Hematologic Malignancies, Division of (671)
  4. Lymphoma (671)
  5. Population Sciences Research Program (671)
  6. Survivorship Research (173)

More Groups

People
  1. Alison Moskowitz (235)
  2. Andrew Zelenetz (169)
  3. Paul Hamlin (140)
  4. Ariela Noy (139)
  5. David Straus (122)
  6. Maria Palomba (112)

More People

Years
  1. 2025 (18)
  2. 2024 (51)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Blood Advances (19)
  5. Leukemia and Lymphoma (19)
  6. Annals of Oncology (18)

More Publications

Publishers
  1. American Society of Hematology (277)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (34)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (23)

More Publishers

Results (671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides or Sezary syndrome: Final results show significant clinical activity and suggest correlation with CD30 expression
    Meeting Abstract

    Kim, Y. H.; Tavallaee, M.; Rozati, S.; Sundram, U.; Salva, K.; Wood, G. S.; Li, S.; Krathen, M.; Nagpal, S.; Reddy, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Duvelisib (IPI-145), a phosphoinositide-3-kinase-δ,γ inhibitor, shows activity in patients with relapsed/refractory T-cell lymphoma
    Meeting Abstract

    Horwitz, S. M.; Porcu, P.; Flinn, I.; Kahl, B. S.; Sweeney, J.; Stern, H. M.; Douglas, M.; Allen, K.; Kelly, P.; Foss, F. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Noy, A.; Portlock, C. S.; Palomba, M. L.; Straus, D. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A phase 1 evaluation of duvelisib (IPI-145), a PI3K-δ,γ inhibitor, in patients with relapsed/refractory iNHL
    Meeting Abstract

    Flinn, I.; Oki, Y.; Patel, M.; Horwitz, S. M.; Foss, F. M.; Sweeney, J.; Allen, K.; Douglas, M.; Steelman, L.; Dunbar, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Pegfilgrastim for patients with newly diagnosed diffuse large B-cell lymphoma undergoing dose adjusted EPOCH-R: The MSKCC experience
    Meeting Abstract

    Lunning, M. A.; Maragulia, J.; Horwitz, S. M.; Moskowitz, C. H.; Noy, A.; Zelenetz, A. D.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Modified SMILE (mSMILE) is active in the treatment of extranodal natural killer/T-cell lymphoma: A single center US experience
    Meeting Abstract

    Lunning, M.; Pamer, E.; Maragulia, J.; Straus, D.; Yahalom, J.; Moskowitz, A.; Zelenetz, A. D.; Horwitz, S.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin in combination with CHP in patients (pts) with newly-diagnosed CD30+ peripheral T-cell lymphomas (PTCL): 2-year follow-up
    Meeting Abstract

    Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Illidge, T.; Huebner, D.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors
    Journal Article

    Pulitzer, M.; Myskowski, P. L.; Horwitz, S. M.; Querfeld, C.; Connolly, B.; Li, J.; Murali, R.
    Pathology (2014)

    Fulltext@MSK | Save